Innoviva Inc (INVA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Innoviva Inc   (NASDAQ: INVA)
 

Innoviva Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Innoviva Inc inventory turnover ratio, the Innoviva Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.65 in the second quarter 2026, a new company high. Average inventory processing period, for the Innoviva Inc in Jun 30 2026 quarter, has decreased to 138 days, compare to 180 days, in the Mar 31 2026 quarter.

Within Healthcare sector 148 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1127 in the first quarter 2026, to 1560.

INVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Innoviva Inc Market Share?

What is Inventory Turnover Ratio?




INVA Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -20.47 % -6.36 % 16.15 % 12.05 % 33.64 %
Y / Y Cost of Sales Growth 189.75 % 87.5 % 374.53 % 150.25 % 18.04 %
Inventory Turnover Ratio (TTM) 2.65 2.03 1.83 1.23 0.89
INVA's Total Ranking # 1560 # 1127 # 1127 # 1119 # 1472
Average inventory processing period 138 180 199 296 411
Seq. Inventory Growth 0.32 % -0.84 % 2.11 % -21.7 % 18.12 %
Seq. Cost of Sales Growth 93.17 % -55.88 % 36 % 150 % 25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 149
Overall Market # 1560

Inventory Turnover Ratio Statistics
High Average Low
2.65 0.98 0.02
(Jun 30 2026)   (Mar 31 2014)




Financial Statements
Innoviva Inc 's Inventories $ 39 Millions Visit INVA's Balance sheet
Innoviva Inc 's Cost of Revenues TTM $ 103 Millions Visit INVA's Income Statement
What are INVA's Sales? Visit INVA's Sales by Segment

Other Inventory Turnover Ratios
Innoviva Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INVA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INVA's Competitors
Inventory Turnover Ratio for INVA's Suppliers
Inventory Turnover Ratio for INVA's Customers

You may also want to know
INVA's Sales Growth Rates INVA's Pe Price to earnings ratio INVA's Receivables Turnover Ratio INVA's Stock Quote
INVA's Net Income Growth Rates INVA's Ps Price to Sales ratio INVA's Sales per Employee INVA's Asset Turnover Ratio
INVA's Net Margin INVA's Pb Price to Book ratio INVA's Financial Strength Ratios INVA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions

Date modified: 2026-09-11T18:47:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.